These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37738672)

  • 61. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.
    Deslandes E; Chevret S
    BMC Med Res Methodol; 2010 Jul; 10():69. PubMed ID: 20670425
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.
    Zhang X; Zhang MJ; Fine J
    Stat Med; 2011 Jul; 30(16):1933-51. PubMed ID: 21557288
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of clustered competing risks data using subdistribution hazard models with multivariate frailties.
    Ha ID; Christian NJ; Jeong JH; Park J; Lee Y
    Stat Methods Med Res; 2016 Dec; 25(6):2488-2505. PubMed ID: 24619110
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new approach to regression analysis of censored competing-risks data.
    Jin Y; Lai TL
    Lifetime Data Anal; 2017 Oct; 23(4):605-625. PubMed ID: 27502000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Penalized variable selection for cause-specific hazard frailty models with clustered competing-risks data.
    Rakhmawati TW; Ha ID; Lee H; Lee Y
    Stat Med; 2021 Dec; 40(29):6541-6557. PubMed ID: 34541690
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Penalized variable selection in competing risks regression.
    Fu Z; Parikh CR; Zhou B
    Lifetime Data Anal; 2017 Jul; 23(3):353-376. PubMed ID: 27016934
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Misspecified regression model for the subdistribution hazard of a competing risk.
    Beyersmann J; Schumacher M
    Stat Med; 2007 Mar; 26(7):1649-51. PubMed ID: 17054104
    [No Abstract]   [Full Text] [Related]  

  • 69. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Survival analysis in the presence of competing risks.
    Zhang Z
    Ann Transl Med; 2017 Feb; 5(3):47. PubMed ID: 28251126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regularized Weighted Nonparametric Likelihood Approach for High-Dimension Sparse Subdistribution Hazards Model for Competing Risk Data.
    Tapak L; Kosorok MR; Sadeghifar M; Hamidi O; Afshar S; Doosti H
    Comput Math Methods Med; 2021; 2021():5169052. PubMed ID: 34589136
    [TBL] [Abstract][Full Text] [Related]  

  • 73. stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.
    Mozumder SI; Rutherford MJ; Lambert PC
    Stata J; 2017; 17(2):462-489. PubMed ID: 30305806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Competing risk regression models for epidemiologic data.
    Lau B; Cole SR; Gange SJ
    Am J Epidemiol; 2009 Jul; 170(2):244-56. PubMed ID: 19494242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Considerations of Competing Risks Analysis in Cardio-Oncology Studies:
    Li Y; Sun L; Burstein DS; Getz KD
    JACC CardioOncol; 2022 Sep; 4(3):287-301. PubMed ID: 36213358
    [TBL] [Abstract][Full Text] [Related]  

  • 76. What Is the Effect of Using a Competing-risks Estimator when Predicting Survivorship After Joint Arthroplasty: A Comparison of Approaches to Survivorship Estimation in a Large Registry.
    Cuthbert AR; Graves SE; Giles LC; Glonek G; Pratt N
    Clin Orthop Relat Res; 2021 Feb; 479(2):392-403. PubMed ID: 33105301
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis.
    Baena-Díez JM; Peñafiel J; Subirana I; Ramos R; Elosua R; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo-Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; García-Lareo M; Gómez de la Cámara A; Lapetra J; Quesada M; Marrugat J; Medrano MJ; Berjón J; Frontera G; Gavrila D; Barricarte A; Basora J; García JM; Pavone NC; Lora-Pablos D; Mayoral E; Franch J; Mata M; Castell C; Frances A; Grau M;
    Diabetes Care; 2016 Nov; 39(11):1987-1995. PubMed ID: 27493134
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Competing risk of mortality in association studies of non-fatal events.
    Buzkova P
    PLoS One; 2021; 16(8):e0255313. PubMed ID: 34388170
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Determining the Risk Factors Affecting on Death Due to Colorectal Cancer Progression: Survival Analysis in the Presence of Competing Risks.
    Safari M; Mahjub H; Esmaeili H; Abbasi M; Roshanaei G
    J Gastrointest Cancer; 2022 Jun; 53(2):348-355. PubMed ID: 33656691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.